- Clinical Trials
- April 2025
- 60 Pages
Global
From €895EUR$1,000USD£787GBP
€1118EUR$1,250USD£983GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €895EUR$1,000USD£787GBP
€1118EUR$1,250USD£983GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €895EUR$1,000USD£787GBP
€1118EUR$1,250USD£983GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €895EUR$1,000USD£787GBP
€1118EUR$1,250USD£983GBP
- Report
- May 2025
- 110 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- October 2025
Global
From €4384EUR$4,900USD£3,854GBP
- Report
- July 2025
Global
From €4384EUR$4,900USD£3,854GBP
- Report
- May 2025
- 100 Pages
Global
From €4384EUR$4,900USD£3,854GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- September 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- September 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- September 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- September 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more